November 11, 2019
Bi-WEEKLY RECAP OF PORTFOLIO COMPANIES IN THE NEWS:
- Avicanna Completed First Commerical Exports of CBD to South Africa and the UK, And Announces Voluntary Lock-Up Agreements for Key Insiders AS WELL As MANAGEMENT CHANGES
- Vivo Cannabis and CB2 Insights Enter Technology and Research Partnership AND ANNOUNCE Release Date Of Q3 Financials
- Next Green Wave Expands Distribution of its Cannabis Products Via Direct Delivery Service
- Jushi To report Third qaurter Financial Results on November 15, 2019
- Terrascend Names Jason Ackerman Executive Chairman and Closes on Second Tranche of Non-brokered private Placement of Unsecured Convertible Debentures and warrants
- Vireo Announces Bruce Linton As New Executive Chairman
- IM CAnnabis BEgins Trading On The CSE Under the SYmbol “IMCC”
Avicanna Inc. (“Avicanna”, TSX: AVCN), part of CGOC’s public portfolio, is a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products.
October 24, 2019 – Announced that Santa Marta Golden Hemp S.A.S. (“SMCH”), its majority owned subsidiary, has completed commercial exports of its AureusTM brand of CBD-based products to South Africa and the United Kingdom. The Aureus brand of products include an organic and sustainable line of plant-derived active pharmaceutical ingredients (“API’s”) and bulk CBD formulations developed by Avicanna in collaboration with SMCH and Sativa National S.A.S. (“Sativa Nativa”), which is also a majority owned subsidiary of Avicanna.
To read the full release follow this link.
October 29, 2019 – Announced that executive officers and directors have entered into voluntary lock-up agreements to extend the term of their lock-up periods, affecting approximately 7.7 million shares. The Company also announced that Kyle Langstaff has stepped down as Vice President (Operations) and has concurrently entered into a lock-up agreement to restrict the disposition of his common shares. In addition, the Company’s board of directors has separated the roles of Chairman and Chief Executive Officer. The board of directors also decided to separate the roles of Chairman and Chief Executive Officer. Mr. Aras Azadian will continue as the Company’s Chief Executive Officer. Avicanna’s board of directors appointed Dr. Chandrakant Panchal, current independent Lead Director, as the Company’s Non-Executive Chairman, effective immediately.
To read the full release follow this link, To learn more about Avicanna please visit them at www.avicanna.com.
Vivo Cannabis Inc. (“Vivo”) (TSX-V: VIVO), part of CGOC’s public portfolio, based in Napanee, Ontario, is recognized for trusted, high-quality products and services and operates world-class indoor cultivation facilities with proprietary plant-growing technology.
October 29, 2019 – Vivo announced entering into a technology and multi-phase research agreement with CB2 Insights (“CB2”, CSE; CBII), a leading data-driven company supporting medical cannabis (also one of CGOC’s public portfolio holdings). The partnership will focus on implanting a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2’s leading technology platform “Sail”, and research capabilities. The Joint Venture will aim to increase the collection of real-world data to assist health care stakeholders in making informed decision on new cannabis-based treatments for patients. In collaboration, Vivo and CB2 will look to uncover data trends and insights from Canada that will help inform ventures in the international marketplace.
To read the full release follow this link.
November 1, 2019 – announced that senior management will host a conference call to discuss the Company’s third quarter 2019 results. The Company will release its results for the third quarter on Thursday, November 14, 2019, after the close of markets.
Next Green Wave Holdings Inc. (“Next Green Wave”) (CSE: NGW), part of CGOC’s public portfolio, is a fully integrated premium cannabis producer with 8 legacy brands and over 45 products marketed through its WEARESDC brand house.
October 31, 2019 – Next Green Wave announced that a selected line of tis products will now be available by means of direct delivery service in San Diego, through its distribution partners (Mankind, Columbia Care and March and Ash). Next Green Wave is also further enhancing its distribution network in Los Angeles by launching its products at premier dispensary, “Genius”. The distribution network now consists of over 35 access points across 13 states.
Jushi Holginds Inc. (“Jushi”) (NEO: JUSH.B), part of CGOC’s public portfolio, is a globally- focused cannabis and hemp company led by an industry leading management team.
October 31, 2019 – Jushi expects to report its financial results for the third quarter ended September 30, 2019 before market open on Friday November 15, 2019. Management will host a conference call and audio webcast the morning of November 15, 2019 at 8:30am ET, to answer questions on its operations and financial highlights.
To read the full release follow this link, to learn more about Jushi please visit them at www.jushico.com.
TerrAscend Cor. (“TerraAscend”) (CSE: TER), a part of CGOC’s public portfolio, is the first and only global cannabis company licensed for sales in Canada, the US, and the EU.
November 4, 2019 – TerrAscend announced key changes to its board of directors and executive team including the appointment of Jason Ackerman (former founder and CEO of online grocer, FreshDrect), as Executive Chairman effective immediately. Mr. Ackerman will oversea day-to-day operations and serve alongside Jason Wild (Chairman of the board), and Michael Nashat (CEO). Mr. Ackerman is an accomplished leader and business builder, who pioneered the development of the online grocery industry.
To read the full release follow this link.
November 7, 2019 – TerrAscend closed the second tranche of the previously announced non-brokered private placement of units of TerrAscend (the “Offering”), for additional gross proceeds of approximately $4.76 million. Each unit in the Offering is comprised of one secured convertible debeneture and 25.2 common share purchase warrants of TerrAscend. The first tranche of the Offering was previously closed providing gross proceeds of $10 million, consisting of a lead order from Canopy Rivers Inc. The proceeds will be used to fund various growth initiatives, capital expenditures, working capital and general corporate purposes. The next tranche of the Offering is expected to close in the coming weeks.
IM Cannabis Corp (“IMCC”, CSE: VREO, formerly I.M.C. Holdings Ltd.), part of CGOC’s private portfolio, is a is a leading Israeli-based medical cannabis provider offering a full spectrum of government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade in Europe.
November 5, 2019 – IMCC commenced trading on the Canadian Securities Exchange (“CSE”), under the symbol “IMMC”, on November 5, 2019, at closing price of $0.63 on its first day of trading. IMCC becomes the first Israeli medical cannabis operator to list its shares in Canada. The listing follows the recent completion of its reverse takeover by Israeli-based IMC Holdings Ltd. that included a private placement offering of subscription receipts for gross proceeds of approximately CAD$20.4 million. Focus Medical Herbs Ltd. (“Focus Medical”), a licensed medical cannabis producer in Israel with whom IMCC has an exclusive commercial agreement to contribute it’s intellectual property and branding, has recognized revenue of CAD$4.3 million in the first half of 2019 from operations in Israel, a 180% increase in Focus’ sales over the prior year. The first cycle of production has been planted by the IMCC’s supply partners in Europe and the initial shipment to Germany is expected in Q2 2020. IMCC continues to expand its cultivation and distribution network across the fast-growing European Union with additional EU-GMP cultivation facilities and supply sources in Portugal and Greece progressing according to plan. Opportunistically evaluating M&A growth opportunities and joint ventures with top manufacturers and leaders in their respective consumer segments.
To learn more about IMCC please visit them at www.imcannabis.com.
Vireo Health International Inc. (“Vireo”, CSE: VREO), part of CGOC’s public portfolio, is a leading physician-led, science-focused, multi-state cannabis company.
November 7, 2019 – Vireo announced that Bruce Linton (founder and former CEO of Canopy Growth Corporation and co-founder of Tweed Marijuana Incorporated), was appointed Executive Chairman. Mr. Linton will serve on the board of directors and be actively involved in the business, working closely with Vireo CEO & Founder, Kyle Kingsly, spearheading Vireo’s strategic decision-making, capital markets activity and future partnerships.
|E-UPDATES – Sign up here to be included in our email blasts and receive timely updates
For further information please contact Cannabis Growth Opportunity Corporation: